Mostrar o rexistro simple do ítem

dc.contributor.authorHelmy, Remon
dc.contributor.authorDuerinckx, Nathalie
dc.contributor.authorDe Geest, Sabina
dc.contributor.authorDenhaerynck, Kris
dc.contributor.authorBerben, Lut
dc.contributor.authorRussell, Cynthia L.
dc.contributor.authorCleemput, Johan Van
dc.contributor.authorCrespo-Leiro, María Generosa
dc.contributor.authorDobbels, Fabian
dc.date.accessioned2018-08-24T10:52:35Z
dc.date.issued2018-05-13
dc.identifier.citationHelmy R, Duerinckx N, De Geest S, Denhaerynck K, Berben L, Russell CL, et al. The international prevalence and variability of nonadherence to the nonpharmacologic treatment regimen after heart transplantation: findings from the cross‐sectional BRIGHT study. Clin Transplant. 2018; 32(7):e13280es_ES
dc.identifier.issn1399-0012
dc.identifier.urihttp://hdl.handle.net/2183/20976
dc.description.abstract[Abstract] Introduction. Heart transplant (HTx) recipients need to follow a complex therapeutic regimen. We assessed the international prevalence and variability in nonadherence to six nonpharmacologic treatment components (physical activity, sun protection, diet, alcohol use, nonsmoking, and outpatient follow‐up visits). Methods. We used self‐report data of 1397 adult HTx recipients from the 36‐HTx‐center, 11‐country, 4‐continent, cross‐sectional BRIGHT study (ClinicalTrials.gov ID: NCT01608477). The nonadherence definitions used were as follows: Physical activity: <3 times/wk 20 minutes’ vigorous activity, <5 times/wk 30 minutes’ moderate activity, or <5 times/wk a combination of either intensity; Sun protection: not “always” applying any sun protection; Diet: not “often” or “always” following recommended diet(s); Alcohol use: >1 alcoholic drink/d (women) or >2 drinks/d (men); Smoking: current smokers or stopped <1 year before; Follow‐up visits: missing ≥1 of the last 5 outpatient follow‐up visits. Overall prevalence figures were adjusted to avoid over‐ or underrepresentation of countries. Between‐country variability was assessed within each treatment component via chi‐square testing. Results. The adjusted study‐wide nonadherence prevalence figures were as follows: 47.8% for physical activity (95% CI [45.2‐50.5]), 39.9% for sun protection (95% CI [37.3‐42.5]), 38.2% for diet recommendations (95% CI [35.1‐41.3]), 22.9% for alcohol consumption (95% CI [20.8‐25.1]), 7.4% for smoking cessation (95% CI [6.1‐8.7]), and 5.7% for follow‐up visits (95% CI [4.6‐6.9]). Significant variability was observed between countries in all treatment components except follow‐up visits. Conclusion. Nonadherence to the post‐HTx nonpharmacologic treatment regimen is prevalent and shows significant variability internationally, suggesting a need for tailored adherence‐enhancing interventions.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.relation.urihttps://doi.org/10.1111/ctr.13280es_ES
dc.rightsThis is the peer reviewed version of an article which has been published in final form at Wiley Online LIbrary. This article may be used for non-commercial purposes in accordance with Wiley Terms and conditions for self-archiving.es_ES
dc.subjectAdherencees_ES
dc.subjectCompliancees_ES
dc.subjectHealth behaviorses_ES
dc.subjectHeart transplantationes_ES
dc.subjectNonpharmacologic treatmentes_ES
dc.titleThe international prevalence and variability of nonadherence to the nonpharmacologic treatment regimen after heart transplantation: findings from the cross‐sectional BRIGHT studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/embargoedAccesses_ES
dc.date.embargoEndDate2019-05-13es_ES
dc.date.embargoLift2019-05-13
UDC.journalTitleClinical Transplantationes_ES
UDC.volume32es_ES
UDC.issue7es_ES
UDC.startPagee13280es_ES


Ficheiros no ítem

Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem